Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi signs 2nd biotech deal of the day
Sanofi is paying Adel $80 million in cash, with the total deal potentially reaching up to $1.04 billion, plus royalties.
Gabrielle Masson
Dec 15, 2025 5:50pm
Pfizer, Sanofi round out '25 with separate autoimmune deals
Dec 15, 2025 11:06am
Sanofi's tolebrutinib woes pile up with FDA delay, trial miss
Dec 15, 2025 9:30am
Sanofi, GSK ink preclinical pacts in hunt for new antibodies
Dec 10, 2025 11:15am
Pfizer details phase 3 data for mRNA flu vaccine
Nov 20, 2025 11:25am
European VC Medicxi closes €500M biotech fund
Nov 14, 2025 3:00am